For the first time in several years, two contested applications for preliminary injunctions (PIs) have been granted by the Federal Court in Australian pharmaceutical patent cases.
The artificial intelligence start-up has reportedly resumed talks with the Defense Department over use of its tools, with high stakes for both.
OpenAI teases “5.4” as reports point to a 1M+ token context window and “extreme reasoning,” amid scrutiny over its Pentagon deal.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results